Skip to content

The effect of Intelligent Exercise Rehabilitation Management System on adherence of home-based cardiac rehabilitation in patients with coronary heart disease: a randomized controlled trial

Construction and implementation science on multi-dimensional cardiac rehabilitation system based on Intelligent Exercise Rehabilitation Management System

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028182
Enrollment
Unknown
Registered
2019-12-14
Start date
2020-07-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Group 1:Phase I: Intelligent exercise rehabilitation management system
Phase II: convenience treatment
Group 2:Phase I: convenience treatment, Phase II: Intelligent exercise rehabilitation management system

Sponsors

Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients between the ages of 18 and 70 years with a diagnosis of CHD, including myocardial infarction, unstable or stable angina, who are treated with PCI therapy during their current admission will be eligible for inclusion. All participants will be required to personally own an operational smartphone, have an active WeChat account and sufficient Chinese language proficiency.

Exclusion criteria

Exclusion criteria: contra-indications to exercise rehabilitation (eg, untreated ventricular tachycardia, severe heart failure, uncontrolled hypertension or hypotension, significant exercise limitations), an inability to operate the IERMS for the purpose of the trial (eg, vision, hearing, cognitive or dexterity impairment), lack of internet access at place of residence or having pre-existing comorbid disease with a life expectancy of <1 year.

Design outcomes

Primary

MeasureTime frame
Adherence of home-based cardiac rehabilitation;

Secondary

MeasureTime frame
VO2peak (peak oxygen uptake);Generalized Anxiety Disorder Scale-7 item, GAD-7;Patients’ Health Questionnaire Depression Scale-9 item, PHQ-9;Health-Related Quality of Life,HRQoL12;General Self Efficacy Scale, GSES;satisfaction;

Countries

China

Contacts

Public ContactLi Feng

Jilin University

fli@jlu.edu.cn+86 17790089009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026